RecruitingNCT06534658

Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia

Sponsor

Ruijin Hospital

Enrollment

1,000 participants

Start Date

Jul 30, 2020

Study Type

OBSERVATIONAL

Conditions

Image Alzheimer Disease

Summary

This project is a multicenter observational study that establishes a longitudinal cohort of patients with Alzheimer's disease and other dementias based on neuroimaging, molecular imaging, biological and digital markers to explore new solutions such as dementia disease mechanism, diagnosis, condition evaluation, and prognosis assessment.

Eligibility

Min Age: 50 YearsMax Age: 85 Years

Inclusion Criteria3

Patients aged ≥50 and ≤85 years old, male or female;
Meet the diagnostic criteria for dementia or MCI;
Neuropsychological score: MMSE 15-28 points, CDR ≤ 1 point; ④ Patients and their families are informed and sign the informed consent form

Exclusion Criteria7

The presence of other neurological diseases that may cause brain dysfunction (such as depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, normal intracranial pressure hydrocephalus, etc.);
The presence of other systemic diseases that may cause cognitive impairment (such as liver dysfunction, renal dysfunction, thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.);
Suffering from a disease that makes it impossible to cooperate with cognitive examinations;
The presence of contraindications to MRI;
The presence of mental and neurological retardation;
Refusing to draw blood;
Refusing to sign the informed consent form.